Continued treatment with secukinumab is associated with high retention or regain of response. (Record no. 29576600)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01380 a2200433 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518033349.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202105s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1365-2133 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1111/bjd.17991 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Augustin, M |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20210514 |
| 245 00 - TITLE STATEMENT | |
| Title | Continued treatment with secukinumab is associated with high retention or regain of response. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The British journal of dermatology |
| Date of publication, distribution, etc. | 01 2020 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 67-75 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Etanercept |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Psoriasis |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Randomized Controlled Trials as Topic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Severity of Illness Index |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ustekinumab |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Thaci, D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Eyerich, K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pinter, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Radtke, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lauffer, F |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mrowietz, U |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gerdes, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pariser, D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lebwohl, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sieder, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Melzer, N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Reich, K |
| 773 0# - HOST ITEM ENTRY | |
| Title | The British journal of dermatology |
| Related parts | vol. 182 |
| -- | no. 1 |
| -- | p. 67-75 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1111/bjd.17991">https://doi.org/10.1111/bjd.17991</a> |
| Public note | Available from publisher's website |
No items available.